Literature DB >> 15630417

How have patient advocates in the United States benefited cancer research?

Deborah Collyar1.   

Abstract

Cancer patient advocates represent those affected by cancer and have a broad view of cancer research. They are involved in many diverse cancer research committees, where they can help tackle old problems from new perspectives that often differ from government, academic, medical and scientific approaches. In this role, patient advocates have aided the development of educational dialogue between investigators and patient communities and assisted in streamlining cancer research policies and clinical trials.

Entities:  

Mesh:

Year:  2005        PMID: 15630417     DOI: 10.1038/nrc1530

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  5 in total

1.  Redressing past wrongs: changing the common rule to increase minority voices in research.

Authors:  William C Rencher; Leslie E Wolf
Journal:  Am J Public Health       Date:  2013-10-17       Impact factor: 9.308

Review 2.  From Individuals to International Policy: Achievements and Ongoing Needs in Diabetes Advocacy.

Authors:  Marisa E Hilliard; Sean M Oser; Kelly L Close; Nancy F Liu; Korey K Hood; Barbara J Anderson
Journal:  Curr Diab Rep       Date:  2015-09       Impact factor: 4.810

3.  PartecipaSalute, an Italian project to involve lay people, patients' associations and scientific-medical representatives in the health debate.

Authors:  Paola Mosconi; Cinzia Colombo; Roberto Satolli; Alessandro Liberati
Journal:  Health Expect       Date:  2007-06       Impact factor: 3.377

4.  Putting patients first: development of a patient advocate and general practitioner-informed model of patient-centred care.

Authors:  Bryce Brickley; Lauren T Williams; Mark Morgan; Alyson Ross; Kellie Trigger; Lauren Ball
Journal:  BMC Health Serv Res       Date:  2021-03-20       Impact factor: 2.655

5.  NCI's publication affiliation conundrum: Reframing innovation to incentivize an equitable path for advocate representation.

Authors:  Susan Samson; Jason J Northey; Irene Acerbi; Andrei Goga; Carl L Flink; Valerie M Weaver; Mark A LaBarge
Journal:  Transl Oncol       Date:  2021-12-30       Impact factor: 4.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.